Is your child currently experiencing gastrointestinal disease flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce painful joints, mouth sores, constant need to poop, weight loss, and/or joint pain associated with gastrointestinal disease.
If you’re concerned about how gastrointestinal disease affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing CD and UC flare-ups? Local research is testing a potential new medication to see if it may reduce fever, joint pain, bloody stool, chronic fatigue, and/or canker sores associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing Crohn’s and UC flare-ups? Local clinical research is testing a potential new medication to see if it may reduce diarrhea with blood and pus, failure to thrive, diarrhea, chronic fatigue, and/or canker sores associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for young people aged 2 to 17 years to join a CD trial to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or Crohn’s and ulcerative colitis (including associated symptoms such as recurrent diarrhea, fatigue, rectal pain, weight loss and/or anemia), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

We are looking for children 2 to 17 years of age to join a CD clinical trial to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or moderately to severely active IBD (including associated symptoms such as diarrhea with blood, kidney stones, bloody stool, malnutrition and/or anemia), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local Crohn’s disease (CD) trial is testing a potential new medication to see if it may reduce urgency to defecate, iron deficiency, abdominal pain, chronic fatigue, and/or liver disease associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the Crohn’s disease (CD) trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for 2–17 year olds to join a Crohn’s disease (CD) clinical research to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or Crohn’s disease (CD) (including associated symptoms such as joint pain, fatigue, cramps, weight loss and/or eye pain), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the GI clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Is your child currently experiencing Crohn’s and UC flare-ups? Local CD research is testing a potential new medication to see if it may reduce cramps, stomach pain, rectal pain, weight loss, and/or anemia associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the CD research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for young people aged 2 to 17 years to join a Crohn’s disease medical research study to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or Crohn’s (including associated symptoms such as swollen joints, inflammation of the bowel or intestine, bloody stool, malnutrition and/or anemia), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing Crohn’s flare-ups? Local Crohn’s disease (CD) research study is testing a potential new medication to see if it may reduce recurrent diarrhea, stomach pain, bloody stool, weight loss, and/or anemia associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the Crohn’s disease (CD) research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.